antibiotics Flashcards
penicillin moa
bind PBPs (transpeptidases) and block transpeptidase cross-linking for peptidoglycan; activate autolytic enzymes
penicillin clinical use
gram +, neisseria meningitidis, and syphilis
penicillin tox
hypersensitivity reactions, hemolytic anemia
penicillin resistance
penicillinase in bacteria (beta-lactamase) cleaves beta-lactam ring
aminopenicillins (drugs)
amoxicillin, ampicillin
aminopenicillin clinical use
extended-specturm penicillin - H. flu, e. coli, listeria, proteus, salmonella, shigella, enterococci
penicillinase resistant penicillins
oxacillin, nafcillin, dicloxacillin
penicillinase resistant penicillin clinical use
s. aureus
aminopenicillin resistance
penicillinase in bacteria (beta-lactamase) cleaves beta-lactam ring
penicillinase resistant penicillins mechanism
binds PBPs; bulky R group blocks access of beta latamase to the beta lactam ring
beta-lactamase inhibitors
clavulanic acid, sulbactam, tazobactam
first generation cephalosporins (drugs)
cefazolin and cephalexin
1st gen cephalosporins use
proteus, e.coli, klebsiella, gram + cocci
2nd gen cephalosporin drugs
cefoxitin, cefaclor, cefuroxime
2nd gen cephalosporin use
h. flu, enterobacter, neisseria, proteus, E.coli, klebsiella, serratia, Gram + cocci
3rd gen. cephalosporin drugs
ceftriaxone, cefotaxiime, ceftazidime
3rd gen cephalosporin use
serious gram negative infections resistant to other beta lactams
ceftriaxone: meningitis and gonorrhea
ceftazidime: pseudomonas
4th gen cephalosporin drug
cefepime
cefepime use
pseudomonas and gram +
5th generation cephalosporin drug
ceftaroline
ceftaroline use
broad gram + and gram - coverage, including MRSA; does not cover pseudomonas
cephalosporin toxicity
hypersensitivity, vit K deficiency, low cross-reactivity with PCN, increased nephrotoxicity of aminoglycosides
aztreonam moa
monobactam resistant to beta lactamases; prevents peptidoglycan crosslinking by binding PBP-3; synergistic with ahminoglycosides
aztreonam use
gram negative rods only; no activity against gram + or anaerobes; nontoxic
carbapenems drugs
imipenem, meropenem, ertapenem, doripenem
carbapenem moa
broad-spectrum beta-lactamase resistant
imipenem administration
must be given with cilastatin (inhibitor of renal dehydropeptidase I) to decrease inactivation of the drug in renal tubules
carbapenem clinical use
gram + cocci, gram-neg. rods and anaerobes; wide spectrum;
carbapenem toxicity
GI, skin rash, CNS toxicity, seizures (esp. meropenem)